Earnings Call · Q2 FY2024·2024-08-08

Q2 24EPS -100.00%*·Rev n/aQ1 24EPS +22.22%·Rev n/aQ4 23EPS +14.29%·Rev n/aQ3 23EPS +38.89%·Rev n/a⚠ consensus missing

Vaxart, Inc. VXRT

Steven Lo — Chief Executive Officer

James Cummings — Likely Chief Medical Officer or similar clinical leadership role

Phil Lee — Chief Financial Officer

−8.0%1d on move date−8.4% vs SPY3d−4.8%5d+18.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VXRT calls or request research access.

More VXRT calls Browse calls Request research access